Illumina, Inc. (ILMN) income statement
NASDAQ · Healthcare · Medical - Diagnostics & Research · 8,600 employees · CEO Jacob Thaysen
- Price
- $235.99 -18.64%
- Market cap
- $35.6B
- Enterprise value
- $36.6B
- Last report
- Q3 '26 filed 2026-10-30
- Next report
- 2027-02-04
Illumina, Inc. (ILMN) reported revenue of $1.13B for Q3 '26 (+4.2% year on year), operating income of $305M (27.0% of revenue) and net income of $220M. Over the last four quarters revenue was $4.54B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.12B | $1.08B | $1.11B | $1.08B | $1.1B | $1.04B | $1.06B | $1.08B | $1.16B | $1.09B | $1.16B | $1.13B | |
| Cost of revenue | $448M | $409M | $391M | $335M | $376M | $356M | $340M | $351M | $382M | $370M | $389M | $299M | |
| Gross profit | $674M | $667M | $721M | $745M | $728M | $685M | $717M | $732M | $778M | $721M | $770M | $830M | |
| Research & development | $341M | $338M | $325M | $253M | $255M | $241M | $243M | $228M | $238M | $240M | $252M | $244M | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $273M | $281M | |
| Other operating expenses | $12M | $1M | $1.89B | -$488M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating expenses | $838M | $778M | $2.36B | $4M | $526M | $501M | $495M | $501M | $521M | $512M | $525M | $525M | |
| Operating income | -$164M | -$111M | -$1.64B | $741M | $202M | $184M | $222M | $231M | $257M | $209M | $245M | $305M | |
| Interest income | $11M | $12M | $13M | $11M | $10M | $11M | $10M | $9M | $10M | $11M | $0 | $0 | |
| Interest expense | $18M | $18M | $20M | $36M | $25M | $25M | $25M | $25M | $26M | $24M | $0 | $0 | |
| Other non-operating income (gains on investments, FX ...) | -$15M | -$20M | $319M | -$15M | -$11M | -$23M | -$109M | -$14M | -$147M | $28M | -$15M | $41M | |
| Total non-operating income | -$3M | $2M | -$339M | -$21M | -$14M | -$2M | $84M | -$11M | $121M | -$52M | $15M | -$41M | |
| Income before tax | -$167M | -$109M | -$1.98B | $720M | $188M | $182M | $306M | $220M | $378M | $157M | $260M | $264M | |
| Income tax | $8M | $17M | $12M | $15M | $1M | $51M | $71M | $70M | $44M | $23M | $53M | $44M | |
| Net income | -$175M | -$126M | -$1.99B | $705M | $187M | $131M | $235M | $150M | $334M | $134M | $207M | $220M | |
| EPS (basic) | -$1.11 | -$0.79 | -$12.50 | $4.43 | $1.18 | $0.82 | $1.50 | $0.98 | $2.18 | $0.88 | $1.37 | $1.46 | |
| EPS (diluted) | -$1.11 | -$0.79 | -$12.50 | $4.41 | $1.17 | $0.82 | $1.50 | $0.97 | $2.17 | $0.87 | $1.35 | $1.43 | |
| Shares (basic, weighted) | 159M | 159M | 159M | 159M | 159M | 159M | 157M | 153M | 153M | 153M | 151M | 151M | |
| Shares (diluted, weighted) | 159M | 159M | 159M | 160M | 160M | 159M | 157M | 154M | 154M | 154M | 153M | 154M | |
| Depreciation & amortization | $109M | $108M | $105M | $70M | $71M | $69M | $68M | $67M | $67M | $69M | $70M | $71M | |
| EBITDA | -$40M | $17M | -$1.85B | $826M | $283M | $276M | $399M | $312M | $471M | $250M | $330M | $335M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.75B | $3.33B | $3.54B | $3.24B | $4.53B | $4.58B | $4.5B | $4.37B | $4.34B | |
| Cost of revenue | $732M | $926M | $1.03B | $1.08B | $1.04B | $1.37B | $1.61B | $1.76B | $1.51B | $1.45B | |
| Gross profit | $1.67B | $1.83B | $2.3B | $2.47B | $2.2B | $3.15B | $2.97B | $2.74B | $2.86B | $2.89B | |
| Research & development | $504M | $546M | $623M | $647M | $682M | $1.19B | $1.32B | $1.35B | $1.17B | $951M | |
| Other operating expenses | -$9M | $0 | $0 | $0 | $0 | $0 | $4.53B | $847M | $1.43B | $0 | |
| Operating expenses | $1.08B | $1.22B | $1.42B | $1.48B | $1.62B | $3.28B | $7.15B | $3.81B | $3.69B | $2.03B | |
| Operating income | $587M | $606M | $883M | $985M | $580M | -$123M | -$4.18B | -$1.07B | -$833M | $864M | |
| Interest income | $10M | $19M | $44M | $75M | $41M | $0 | $11M | $58M | $46M | $40M | |
| Interest expense | $33M | $37M | $57M | $52M | $49M | $61M | $26M | $77M | $100M | $101M | |
| Other non-operating income (gains on investments, FX ...) | -$7M | -$474M | -$68M | -$185M | -$325M | -$1.07B | $131M | -$29M | $246M | -$323M | |
| Total non-operating income | -$26M | $437M | $11M | $133M | $276M | $1.01B | -$157M | -$48M | -$346M | $222M | |
| Income before tax | $561M | $1.04B | $894M | $1.12B | $856M | $884M | -$4.34B | -$1.12B | -$1.18B | $1.09B | |
| Income tax | $133M | $365M | $112M | $128M | $200M | $122M | $68M | $44M | $44M | $236M | |
| Net income | $463M | $726M | $826M | $1B | $656M | $762M | -$4.4B | -$1.16B | -$1.22B | $850M | |
| EPS (basic) | $3.15 | $4.97 | $5.62 | $6.82 | $4.46 | $5.08 | -$28.05 | -$7.35 | -$7.69 | $5.48 | |
| EPS (diluted) | $3.13 | $4.91 | $5.54 | $6.72 | $4.43 | $5.05 | -$28.05 | -$7.35 | -$7.69 | $5.45 | |
| Shares (basic, weighted) | 147M | 146M | 147M | 147M | 147M | 150M | 157M | 158M | 159M | 155M | |
| Shares (diluted, weighted) | 148M | 148M | 149M | 149M | 148M | 151M | 157M | 158M | 159M | 156M | |
| Depreciation & amortization | $141M | $156M | $179M | $188M | $187M | $251M | $394M | $432M | $354M | $270M | |
| EBITDA | $735M | $1.24B | $1.13B | $1.36B | $1.09B | $1.2B | -$3.92B | -$608M | -$725M | $1.46B |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-27, 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-28, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-29, 10-Q 2024-09-29
Data as of 2026-11-02